Cover Image

Cardiovascular adverse events associated with oral antineoplastic therapy

ABSTRACT Objective: To identify in the literature the cardiovascular adverse events resulting from oral antineoplastic therapy. Method: Integrative review of the literature through the SCOPUS, Scientific Electronic Library Online (SciELO), Cumulative Index to Nursing and Allied Health Literature (CI...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jacqueline Mota da Silva (Author), Beatriz da Silva Lima (Author), Thelma Leite de Araújo (Author), Francisca Elisângela Teixeira Lima (Author), Gilmara Holanda da Cunha (Author)
Format:	Book
Published:	Associação Brasileira de Enfermagem.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Hygiene practices for patients with HIV/AIDS
by: Gilmara Holanda da Cunha, et al.

Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
by: William Queiroz Guimarães Wiegandt Ceglio, et al.
Published: (2022)

Fact-Finding Survey and Exploration of Preventive Drugs for Antineoplastic Drug-Induced Oral Mucositis Using the Japanese Adverse Drug Event Report Database
by: Hajime Matsuo, et al.
Published: (2024)

Correlação dos fatores condicionantes básicos para o autocuidado dos pacientes pós-revascularização do miocárdio Correlación de los factores condicionantes básicos para lo autocuidado de los pacientes sometidos a revascularización miocárdica Correlation of basic conditioning factors for selfcare of patients who underwent coronary bypass
by: Francisca Elisângela Teixeira Lima, et al.
Published: (2005)

Adherence to oral antineoplastic therapy
by: R. Olivera-Fernandez, et al.
Published: (2014)

ADVERSE EVENTS IN INTENSIVE CARE: WHAT THEY KNOW THE NURSES
by: Roberto Carlos Lyra da Silva, et al.
Published: (2011)

ADVERSE EVENTS IN INTENSIVE CARE: WHAT THEY KNOW THE NURSES
by: Roberto Carlos Lyra da Silva, et al.
Published: (2011)

ADVERSE EVENTS IN INTENSIVE CARE: WHAT THEY KNOW THE NURSES
by: Roberto Carlos Lyra da Silva, et al.
Published: (2011)

ADVERSE EVENTS IN INTENSIVE CARE: WHAT THEY KNOW THE NURSES
by: Roberto Carlos Lyra da Silva, et al.
Published: (2011)

THE ROLE OF DOPING IN EMERGENCE OF ADVERSE CARDIOVASCULAR EVENTS
by: Nina Đukanović, et al.
Published: (2011)

Biomarkers of Adverse Cardiovascular Events in Kidney Disease
by: L. A. Kamyshnikova, et al.
Published: (2023)

Occlusions in peripherally inserted central venous catheters in pediatric patients in antineoplastic chemotherapy
by: Bruna Irene Cunha Curty de Souza, et al.
Published: (2021)

Risk factors associated with the occurrence of the adverse event phlebitis in hospitalized adult patients
by: Maryana da Silva Furlan, et al.
Published: (2024)

Detection of potential safety signals related to the use of remdesivir and tocilizumab in the COVID era during pregnancy, resorting to open data from the FDA adverse event reporting system (FAERS)
by: Beatriz Marinho Silva Romão, et al.
Published: (2024)

The reasons of the nursing staff to notify adverse events
by: Miriam Cristina Marques da Silva de Paiva, et al.
Published: (2014)

Oral pathogen candida in patients under antineoplastic therapies
by: Martha Rebolledo-Cobos, et al.
Published: (2018)

Construction and validation of educational booklets regarding oral antineoplastics
by: Andrieli Meira COSTA, et al.
Published: (2024)

PREVENTIVE STRATEGIES OF ADVERSE EVENTS WITH POTENTIALLY DANGEROUS MEDICATIONS
by: Flavia Giron Camerini, et al.
Published: (2013)

PREVENTIVE STRATEGIES OF ADVERSE EVENTS WITH POTENTIALLY DANGEROUS MEDICATIONS
by: Flavia Giron Camerini, et al.
Published: (2013)

PREVENTIVE STRATEGIES OF ADVERSE EVENTS WITH POTENTIALLY DANGEROUS MEDICATIONS
by: Flavia Giron Camerini, et al.
Published: (2013)

PREVENTIVE STRATEGIES OF ADVERSE EVENTS WITH POTENTIALLY DANGEROUS MEDICATIONS
by: Flavia Giron Camerini, et al.
Published: (2013)

Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System
by: Matthew S. Duprey, et al.
Published: (2019)

Pharmacovigilance Program impact on notifications of adverse reactions to antineoplastic drug in a university hospital
by: Carlos Alberto WAYHS, et al.
Published: (2024)

Cancer incidence and adverse pregnancy outcome in registered nurses potentially exposed to antineoplastic drugs
by: Le Nhu D, et al.
Published: (2010)

A Risk-Factor Model for Antineoplastic Drug-Induced Serious Adverse Events in Cancer Inpatients: A Retrospective Study Based on the Global Trigger Tool and Machine Learning
by: Ni Zhang, et al.
Published: (2022)

Assessing the risk of tumor lysis syndrome associated with the use of antineoplastic agents: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database
by: Dongxuan Li, et al.
Published: (2024)

NURSES' KNOWLEDGE ABOUT ADVERSE EVENTS AND THE CHALLENGES OF REPORTING THESE EVENTS
by: Jamilly Santos Araujo, et al.
Published: (2016)

Nursing orientation given to children in antineoplastic chemotherapy treatment
by: Elaine Freire Cruz, et al.
Published: (2014)

Peripheral Artery Disease Screening in the Community and 1-Year Mortality, Cardiovascular Events, and Adverse Limb Events
by: Kim G. Smolderen, PhD, et al.
Published: (2022)

Antineoplastic therapy administration: Nursing intervention in the relief of suffering
by: Eunice Sá, et al.

The practice of reporting adverse events in a teaching hospital
by: Andréia Guerra Siman, et al.
Published: (2017)

ACESSO DE IDOSOS ÀS UNIDADES DE ATENÇÃO PRIMÁRIA À SAÚDE
by: Lorita Marlena Freitag Pagliuca, et al.
Published: (2017)

Biomarkers and Predictors of Adverse Cardiovascular Events in Different Stages of Chronic Kidney Disease
by: Bojan Stopic, et al.
Published: (2022)

Vorapaxar for Prevention of Major Adverse Cardiovascular and Limb Events in Peripheral Artery Disease
by: Justin T. Morrison MD, et al.
Published: (2022)

Adverse events in rheumatoid arthritis patients under antimalarial treatment-Is there cardiovascular compromise?
by: Pedro Santos-Moreno, et al.
Published: (2023)

Cardiovascular Adverse Events Associated with Monoclonal Antibody Products in Patients with COVID-19
by: Jingrui Zou, et al.
Published: (2022)

Influence of occupational exposure to antineoplastic agents on adverse pregnancy outcomes among nurses: A meta‐analysis
by: Shuhan Liu, et al.
Published: (2023)

Oral Immune-Related Adverse Events - Current Concepts and their Management
by: Mohamed Faizal Asan, et al.
Published: (2021)

Validación de juego educativo para la enseñanza de la valoración cardiovascular Validação de jogo educativo para o ensino da valoração cardiovascular Validation of an educational game for teaching cardiovascular assessment
by: Márcio Flávio Moura de Araújo, et al.
Published: (2010)

Representações de pacientes oncológicos sobre o tratamento de quimioterapia antineoplásica Oncologic patients representations about the antineoplastic chemotherapy treatment
by: Fernanda Furtado da Cunha, et al.
Published: (2017)